Skip to main content
OpenTrials
Completed

NCT Number: NCT06204900

A Post-marketing Study to Evaluate a Novel Surgical Monitoring Technique Using the EARP Nerve Cuff in TLIF Surgery.

The purpose of this study is to evaluate the differences (the effectiveness and the safety) between two different nerve and muscle monitoring devices currently available during a TLIF surgery.

The Endoscopic Assisted Retropsoas (EARP) Nerve Cuff Electrode and Retractor surgical and nerve monitoring tools will be used in addition to standard nerve monitoring tools during the surgery. The choice of standard nerve monitoring equipment is based on the decision of the surgeon and technologist and is not dictated by this study.

These tools will be compared with regards to safety and ability to accurately monitor the nervous system during the surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

22 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Rothman Orthopaedic Institute, Philadelphia, Pennsylvania, United States

Loading trial locations.

About this study

The application of traditional SSEPs and tcMEPs to lumbar nerve root monitoring during TLIF surgery is both challenging and problematic. When applied to lumbar nerve root monitoring, SSEPs and tcMEPs unfortunately suffer in specificity, sensitivity, or both. A surgeon thus cannot confidently rely on these techniques to monitor nerve root function and must guess the likelihood of dysfunction.

Spontaneous EMG (sEMG) is also used to monitor nerve root activity. While sEMG is an excellent indicator of spinal nerve root manipulation, it is a poor diagnostic indicator of dysfunction. 90-95% of sEMG alerts are not associated with dysfunction yielding a high false positive rate and poor specificity, and postoperative deficits are often not associated with sEMG alerts yielding many false negatives and poor sensitivity. The primary utility of sEMG is to use as an indicator of manipulation, which prompts the acquisition of tcMEPs to assess function.

There is a clear need to take the guesswork out of monitoring the functional status of nerve roots at risk during lumbar decompressions and select interbody fusions. During TLIFs, the exiting nerve root is at risk as it courses obliquely across disc space encroaching on the surgical corridor. Standardly, a hand-held retractor is used to retract and protect the nerve root during disc space preparation, implant insertion or even simple decompression. This maneuver and retraction place a particular nerve root at risk, but again, traditional SSEP and tcMEPs are not ideal for monitoring that risk.

The EARP Nerve Cuff Electrode (Retropsoas Technologies) is a novel, Class II, device that is 510(k) cleared by FDA. It conducts electrical signals as a component of intraoperative neuromonitoring, is used with commercially available neuromonitoring systems, and does not stimulate or record the signal itself. The standard connectors at the proximal end interface with the neuromonitoring equipment. The distal nerve cuff electrode partially encircles and contacts the target nerve root. It uses a bipolar configuration to limit current spread. It is available in several inner diameters to accommodate variability in patient nerve root size anatomy.

The EARP Retractor is a Class I device used with a commercially available Retractor system and is only used as an additional 4th blade.

In TLIF surgery, the exiting nerve must be retracted to allow for sufficient access to the intervertebral disc space. The retraction is applied at the medial portion of the nerve root. The application of this retraction may produce activity in the nerve root and/or conduction changes in the nerve root due to temporary manipulation, compression, or ischemia related to the retraction.1

The objective of the study is to demonstrate the ability to safely monitor lumbar nerve root activity and function during retraction using an Endoscopic Assisted Retropsoas (EARP) Nerve Cuff Electrode and an EARP Retractor system during a standard Transforaminal Lumbar Interbody Fusion (TLIF), with improved specificity and sensitivity over traditional monitoring techniques.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Undergoing TLIF between L2-S1

Exclusion criteria

  • Requiring TLIF surgery only at the L5-S1 level
  • Acute lumbar spine trauma requiring immediate intervention
  • Allergy or contraindication to propofol
  • Lower extremity amputation
  • Significant lower extremity edema noted on clinical exam
  • Current treatment with chemotherapy, radiation, or immunosuppression
  • Pregnant, or plans on becoming pregnant in the near future
  • History of allergy to titanium, platinum, aluminum, stainless steel, or silicon

Treatment and study plan

Nerve Cuff and Retractor System

Device

Endoscopic Assisted Retropsoas (EARP) Nerve Cuff Electrode and an EARP Retractor system to safely monitor lumbar nerve root activity and function during a standard Transforaminal Lumbar Interbody Fusion (TLIF).

Primary outcomes

  1. Number of patients that experience an Adverse Device Effect (ADE)

    Time frame: From enrollment through the end of the follow-up assessment at week 6

    Adverse device effect (ADE) - Adverse event (AE) judged by the clinician related to the use of an investigational devices. This includes any AE resulting from insufficient or inadequate instructions for use or the deployment, implantation, installation, or operation, or any malfunctioning of the investigational devices and any event resulting from use error or from unintentional misuse of the investigational devices.

  2. Ability of EARP System to alert the surgeon to nerve irritation during surgery compared to standard IONM monitoring techniques

    Time frame: During the TLIF surgery.

    Signal amplitude at baseline, during initial retraction, and maintenance of retraction will be analyzed for changes using a 50% decrease as a surgeon alert. IONM assessments using traditional electrodes: SSEPs, tcMEPs and tfMEP. IONM assessments using EARP cuff: cuff SSEPs, cuff tcMEPs, and cuff tfMEPs.

Secondary outcomes

  1. Evaluate the specificity and sensitivity of alerts to neurological deficits.

    Time frame: From time of surgery through the end of the follow-up assessment at week 6

    Evaluate the sensitivity and specificity of alerts to neurological deficits (by modality and overall). This will include neurological deficits noted on exams as well as a surrogate measure of deficit defined as an alert which resolves with relaxation of retraction.

  2. Assess monitorability of muscles/nerves

    Time frame: During the TLIF surgery.

    Compare the number of evaluable muscles during the surgery by modality and overall.

  3. Assess the change from baseline to end of surgery for each muscle and modality

    Time frame: From enrollment through the end of the follow-up assessment at week 6

    Assess the lower extremity motor deficits post-surgery based on the ipsilateral lower extremity motor exam performed at Baseline, Post-Surgery, and at the 6-week follow-up visit.

Other outcomes

  1. Evaluate the set-up time required for standard IONM monitoring

    Time frame: During the TLIF surgery

    Time for needle placement, tcMEP Baseline acquisition, tfMEP Baseline acquisition, and needle removal will be calculated and compared to set-up of EARP Nerve Cuff

  2. Analyze sEMG activity and any correlations to MEP data and patient-specific characteristics

    Time frame: From enrollment through the end of the follow-up assessment at week 6

    Analyze sEMG activity and any correlations to MEP data and patient-specific characteristics

  3. Characterize retraction, relaxation and release data

    Time frame: During the TLIF surgery

    Characterize retraction, relaxation and release data for the EARP Device

  4. Evaluate total emergence time for anesthetic regimen

    Time frame: During the TLIF surgery

    Evaluate total emergence time for anesthetic regimen

Sponsors and collaborators

Lead sponsor

Retropsoas Technologies, LLC

Industry

Registry information

Official study title

Evaluation Of A Novel Technique To Monitor Neurophysiological Activity During TLIF Surgery Using The Endoscopic Assisted Retropsoas (EARP) Nerve Cuff Electrode and Retractor With A Commercially Available Lumbar Spine Retractor System

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jan 12, 2024
Registry last updated
Apr 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.